Impact of C-Peptide Preservation on Metabolic and Clinical Outcomes

As C-peptide decreased to non-measureable concentrations, the outcomes changed in a nearly linear manner, with no threshold or breakpoint. While preservation of stimulated C-peptide at =0.2 nmol/L has clinically beneficial outcomes, so also does an increase in the concentration of C-peptide across the range of values (Diabetes)